Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sukumar Pal, Salvador Fernando Ausar, Delia F. Tifrea, Chunmei Cheng, Scott Gallichan, Violette Sanchez, Luis M. de la Maza & Lucian Visan. (2020) Protection of outbred mice against a vaginal challenge by a Chlamydia trachomatis serovar E recombinant major outer membrane protein vaccine is dependent on phosphate substitution in the adjuvant. Human Vaccines & Immunotherapeutics 16:10, pages 2537-2547.
Read now
Read now
Jean-Daniel Masson, Michel Thibaudon, Laurent Bélec & Guillemette Crépeaux. (2017) Calcium phosphate: a substitute for aluminum adjuvants?. Expert Review of Vaccines 16:3, pages 289-299.
Read now
Read now
Charlotte Pinholt, Rune Andersen Hartvig, Natalie J Medlicott & Lene Jorgensen. (2011) The importance of interfaces in protein drug delivery – why is protein adsorption of interest in pharmaceutical formulations?. Expert Opinion on Drug Delivery 8:7, pages 949-964.
Read now
Read now
Stanley L Hem & Harm HogenEsch. (2007) Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Review of Vaccines 6:5, pages 685-698.
Read now
Read now
Articles from other publishers (64)
Cunpei Bo, Xiaoli Wei, Xue Wang, Wenheng Ji, Huan Yang, Yuxiu Zhao & Hui Wang. (2023) Physicochemical properties and adsorption state of aluminum adjuvants with different processes in vaccines. Heliyon 9:8, pages e18800.
Crossref
Crossref
Bingbing Sun, Min Li, Zhiying Yao, Ge Yu & Yubin Ma. 2023.
Nadezhda Angelova, Savina Koleva, Marco Kostadinov & Georgi Yordanov. (2022) Preparation, characterization and protein adsorption properties of nanostructured magnesium whitlockite. Journal of Materials Science 57:47, pages 21571-21582.
Crossref
Crossref
Ge Yu, Zhihui Liang, Zilan Yu, Min Li, Wenqi Yang, Yawei Zhang, Yuhang Zhao, Cheng Yang, Changying Xue, Li Shi & Bingbing Sun. (2022) Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior. npj Vaccines 7:1.
Crossref
Crossref
Ming Qin, Guangsheng Du, Nan Qiao, Zhaofei Guo, Min Jiang, Chunting He, Shuting Bai, Penghui He, Yanhua Xu, Hairui Wang, Tao Gong, Zhirong Zhang & Xun Sun. (2021) Whole‐Cell‐Mimicking Carrier‐Free Nanovaccines Amplify Immune Responses Against Cancer and Bacterial Infection. Advanced Functional Materials 32:10.
Crossref
Crossref
Alex Langford, Michael Bruchsaler & Manish Gupta. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
225
266
.
Thi-Huong Dao, Thi-Quynh-Mai Vu, Ngoc-Trung Nguyen, Thu-Thao Pham, Thi-Lien Nguyen, Shin-ichi Yusa & Tien-Duc Pham. (2020) Adsorption Characteristics of Synthesized Polyelectrolytes onto Alumina Nanoparticles and their Application in Antibiotic Removal. Langmuir 36:43, pages 13001-13011.
Crossref
Crossref
Jean-François Art, Patrice Soumillion & Christine C. Dupont-Gillain. (2020) Use of a quartz crystal microbalance platform to study protein adsorption on aluminum hydroxide vaccine adjuvants: Focus on phosphate-hydroxide ligand exchanges. International Journal of Pharmaceutics 573, pages 118834.
Crossref
Crossref
Sjaikhurrizal El Muttaqi, Etik Mardliyati, Silmi Rahmani, Sabar Pambudi, Siti Maimunah, Ziah Izati Azki, Nurmeilis .Asri Sulfianti, Julham Efendi, Damai Ria Setyaw, Asutiati Nurhasanah & Irvan Faizal. (2019) Intraperitoneal Acute Toxicity of Aluminum Hydroxide Nanoparticle as an Adjuvant Vaccine Candidate in Mice. Journal of Pharmacology and Toxicology 15:1, pages 22-35.
Crossref
Crossref
Youzhi Wang, Xinxin Li, Yiming Zhang, Ling Wang & Zhimou Yang. (2019) A supramolecular hydrogel to boost the production of antibodies for phosphorylated proteins. Chemical Communications 55:82, pages 12388-12391.
Crossref
Crossref
Pongsakorn Thawornpan, Watthanachai Jumpathong, Supinya Thanapongpichat, Luitzen de Jong, Amornrat Phongdara & Hansuk Buncherd. (2019) Mechanistic investigation of phosphoprotein enrichment by fly ash-based chromatography. Journal of Chromatography B 1118-1119, pages 1-6.
Crossref
Crossref
Danina Krajišnik, Tanja Ilić, Ines Nikolić & Snežana Savić. (2019) Established and advanced adjuvants in vaccines' formulation: Mineral adsorbents, nanoparticulate carriers and microneedle delivery systems. Arhiv za farmaciju 69:6, pages 420-451.
Crossref
Crossref
Vishal M. Toprani, Yuan Cheng, Newton Wahome, Harshit Khasa, Lisa A. Kueltzo, Richard M. Schwartz, C. Russell Middaugh, Sangeeta B. Joshi & David B. Volkin. (2018) Structural Characterization and Formulation Development of a Trivalent Equine Encephalitis Virus-Like Particle Vaccine Candidate. Journal of Pharmaceutical Sciences 107:10, pages 2544-2558.
Crossref
Crossref
Jean-François Art, Aurélien vander Straeten & Christine C. Dupont-Gillain. (2017) Immobilization of Aluminum Hydroxide Particles on Quartz Crystal Microbalance Sensors to Elucidate Antigen–Adjuvant Interaction Mechanisms in Vaccines. Analytical Chemistry 90:2, pages 1168-1176.
Crossref
Crossref
Nadezhda Angelova & Georgi Yordanov. (2017) Iron(III) and aluminium(III) based mixed nanostructured hydroxyphosphates as potential vaccine adjuvants: Preparation and physicochemical characterization. Colloids and Surfaces A: Physicochemical and Engineering Aspects 535, pages 184-193.
Crossref
Crossref
Janny Westdijk, Bernard Metz, Nanda Spruit, Wichard Tilstra, Johan van der Gun, Coenraad Hendriksen & Gideon Kersten. (2017) Antigenic fingerprinting of diphtheria toxoid adsorbed to aluminium phosphate. Biologicals 47, pages 69-75.
Crossref
Crossref
Jean-François Art, Aurélien vander Straeten & Christine C. Dupont-Gillain. (2017) NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants. International Journal of Pharmaceutics 517:1-2, pages 226-233.
Crossref
Crossref
E.B. Lindblad & L. Duroux. 2017. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
347
375
.
Laurent Bessemans, Vanessa Jully, Caroline de Raikem, Mathieu Albanese, Nicolas Moniotte, Pascal Silversmet & Dominique Lemoine. (2016) Automated Gravimetric Calibration to Optimize the Accuracy and Precision of TECAN Freedom EVO Liquid Handler. SLAS Technology 21:5, pages 693-705.
Crossref
Crossref
Matthew Mold, Emma Shardlow & Christopher Exley. (2016) Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations. Scientific Reports 6:1.
Crossref
Crossref
Vanessa Jully, Frédéric Mathot, Nicolas Moniotte, Véronique Préat & Dominique Lemoine. (2016) Mechanisms of Antigen Adsorption Onto an Aluminum-Hydroxide Adjuvant Evaluated by High-Throughput Screening. Journal of Pharmaceutical Sciences 105:6, pages 1829-1836.
Crossref
Crossref
Valentina Agnolon, Cristina Bruno, Bruno Galletti, Elena Mori, Mildred Ugozzoli, Carlo Pergola, Derek T. O’Hagan & Barbara C. Baudner. (2016) Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines. Vaccine 34:8, pages 1040-1046.
Crossref
Crossref
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
145
163
.
Vanessa Jully, Nicolas Moniotte, Frédéric Mathot, Dominique Lemoine & Véronique Préat. (2015) Development of a High-Throughput Screening Platform to Study the Adsorption of Antigens onto Aluminum-Containing Adjuvants. Journal of Pharmaceutical Sciences 104:2, pages 557-565.
Crossref
Crossref
Jan ter Meulen, Danilo Casimiro, Beth-Ann Coller, Jon Heinrichs & Akhilesh Bhambhani. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
251
287
.
Erik B. Lindblad. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
33
57
.
Mette Hamborg & Camilla Foged. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery
413
426
.
Emily P. Wen, Ronald Ellis & Narahari S. PujarStanley L. Hem & Cliff T. Johnston. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing
319
346
.
Min Huang & Wei Wang. (2014) Factors affecting alum–protein interactions. International Journal of Pharmaceutics 466:1-2, pages 139-146.
Crossref
Crossref
Yüksel Güzel, Shah Hussain, Matthias Rainer & Günther K. Bonn. (2014) Highly selective enrichment of phosphopeptides using aluminum silicate. Anal. Methods 6:22, pages 9160-9167.
Crossref
Crossref
Xinran Li, Abdulaziz M. Aldayel & Zhengrong Cui. (2014) Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. Journal of Controlled Release 173, pages 148-157.
Crossref
Crossref
Mirjam Kool & Bart N. Lambrecht. 2014. Molecular Vaccines. Molecular Vaccines
633
642
.
Fangjia Lu, Irene Boutselis, Richard F. Borch & Harm HogenEsch. (2013) Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker. Vaccine 31:40, pages 4362-4367.
Crossref
Crossref
Yüksel Güzel, Matthias Rainer, Munazza R. Mirza, Christoph B. Messner & Günther K. Bonn. (2013) Highly selective recovery of phosphopeptides using trypsin-assisted digestion of precipitated lanthanide–phosphoprotein complexes. The Analyst 138:10, pages 2897.
Crossref
Crossref
Sin Hang Lee. (2012) Detection of human papillomavirus (HPV) L1 gene DNA possibly bound to particulate aluminum adjuvant in the HPV vaccine Gardasil®. Journal of Inorganic Biochemistry 117, pages 85-92.
Crossref
Crossref
Yüksel Güzel, Matthias Rainer, Munazza Raza Mirza & Günther K. Bonn. (2012) Highly efficient precipitation of phosphoproteins using trivalent europium, terbium, and erbium ions. Analytical and Bioanalytical Chemistry 403:5, pages 1323-1331.
Crossref
Crossref
Daming Zhu, Shuhui Huang, Holly McClellan, Weili Dai, Najam R. Syed, Elizabeth Gebregeorgis, Gregory E.D. Mullen, Carole Long, Laura B. Martin, David Narum, Patrick Duffy, Louis H. Miller & Allan Saul. (2012) Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer. Vaccine 30:2, pages 189-194.
Crossref
Crossref
Bethany Hansen, Padma Malyala, Manmohan Singh, Yide Sun, Indresh Srivastava, Harm Hogenesch & Stanley L. Hem. (2011) Effect of the strength of adsorption of HIV 1 SF162dV2gp140 to aluminum‐containing adjuvants on the immune response. Journal of Pharmaceutical Sciences 100:8, pages 3245-3250.
Crossref
Crossref
Wei Wang & Manmohan Singh. 2011. Development of Vaccines. Development of Vaccines
327
383
.
Garry L. Morefield. (2011) A Rational, Systematic Approach for the Development of Vaccine Formulations. The AAPS Journal 13:2, pages 191-200.
Crossref
Crossref
Tanya Clapp, Paul Siebert, Dexiang Chen & LaToya Jones Braun. (2011) Vaccines with Aluminum-containing Adjuvants: Optimizing Vaccine Efficacy and Thermal Stability. Journal of Pharmaceutical Sciences 100:2, pages 388-401.
Crossref
Crossref
Wei Wang & Manmohan Singh. (2011) Selection of Adjuvants for Enhanced Vaccine Potency. World Journal of Vaccines 01:02, pages 33-78.
Crossref
Crossref
Stephanie M. Noe, Mark A. Green, Harm HogenEsch & Stanley L. Hem. (2010) Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response. Vaccine 28:20, pages 3588-3594.
Crossref
Crossref
Patricia M. Egan, Mary T. Belfast, Juan A. Giménez, Robert D. Sitrin & Ralph J. Mancinelli. (2009) Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine. Vaccine 27:24, pages 3175-3180.
Crossref
Crossref
Lena Wolff, Jens Flemming, Reinhard Schmitz, Karsten Gröger, Cristina Goso & Christel Müller-Goymann. (2009) Forces determining the adsorption of a monoclonal antibody onto an aluminium hydroxide adjuvant: Influence of interstitial fluid components. Vaccine 27:12, pages 1834-1840.
Crossref
Crossref
Bethany Hansen, Mary Belfast, George Soung, Liping Song, Patricia M. Egan, Robert Capen, Harm HogenEsch, Ralph Mancinelli & Stanley L. Hem. (2009) Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response. Vaccine 27:6, pages 888-892.
Crossref
Crossref
Florian Wolschin & Wolfram Weckwerth. 2008. Plant Proteomics. Plant Proteomics
419
442
.
Bethany Hansen, Anna Sokolovska, Harm HogenEsch & Stanley L. Hem. (2007) Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response. Vaccine 25:36, pages 6618-6624.
Crossref
Crossref
Christina Vessely, Tia Estey, Theodore W. Randolph, Ian Henderson, Rajiv Nayar & John F. Carpenter. (2007) Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants. Journal of Pharmaceutical Sciences 96:9, pages 2375-2389.
Crossref
Crossref
Joan A. Aebig, Gregory E.D. Mullen, Gelu Dobrescu, Kelly Rausch, Lynn Lambert, Olubunmi Ajose-Popoola, Carole A. Long, Allan Saul & Aaron P. Miles. (2007) Formulation of vaccines containing CpG oligonucleotides and alum. Journal of Immunological Methods 323:2, pages 139-146.
Crossref
Crossref
Laura J. Peek, Talia T. Martin, Charity Elk Nation, Shannel A. Pegram & C.Russell Middaugh. (2007) Effects of Stabilizers on the Destabilization of Proteins upon Adsorption to Aluminum Salt Adjuvants. Journal of Pharmaceutical Sciences 96:3, pages 547-557.
Crossref
Crossref
Ilia Z. Romero Méndez, Yi Shi, Harm HogenEsch & Stanley L. Hem. (2007) Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants. Vaccine 25:5, pages 825-833.
Crossref
Crossref
Laura J. Peek, Robert N. Brey & C.Russell Middaugh. (2007) A Rapid, Three-Step Process for the Preformulation of aRecombinant Ricin Toxin A-Chain Vaccine. Journal of Pharmaceutical Sciences 96:1, pages 44-60.
Crossref
Crossref
Dr. Enrique IglesiasOrisley FranchYamilka CarrazanaYadira LobainaDaymir GarcíaJorge SanchezJosé GarcíaDioslaida UrquizaVerena MuzioGerardo GuillénJulio C. Aguilar. (2006) Influence of Aluminum-Based Adjuvant on the Immune Response to Multiantigenic Formulation. Viral Immunology 19:4, pages 712-721.
Crossref
Crossref
Erik B. Lindblad. 2006. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
217
233
.
Roberto A. DePaz, Ian Henderson & Siddharth J. Advant. (2005) Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant. Vaccine 23:31, pages 4029-4035.
Crossref
Crossref
LaToya S. Jones, Laura J. Peek, Jonathan Power, Aaron Markham, Brian Yazzie & C. Russell Middaugh. (2005) Effects of Adsorption to Aluminum Salt Adjuvants on the Structure and Stability of Model Protein Antigens. Journal of Biological Chemistry 280:14, pages 13406-13414.
Crossref
Crossref
Garry L. Morefield, Dongping Jiang, Ilia Z. Romero-Mendez, Robert L. Geahlen, Harm HogenEsch & Stanley L. Hem. (2005) Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid. Vaccine 23:12, pages 1502-1506.
Crossref
Crossref
Garry L. Morefield, Anna Sokolovska, Dongping Jiang, Harm HogenEsch, J. Paul Robinson & Stanley L. Hem. (2005) Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23:13, pages 1588-1595.
Crossref
Crossref
Dongping Jiang, Gnanasiri S. Premachandra, Cliff Johnston & Stanley L. Hem. (2004) Structure and adsorption properties of commercial calcium phosphate adjuvant. Vaccine 23:5, pages 693-698.
Crossref
Crossref
Erik B Lindblad. (2004) Aluminium compounds for use in vaccines. Immunology & Cell Biology 82:5, pages 497-505.
Crossref
Crossref
Garry L. Morefield, Harm HogenEsch, J.Paul Robinson & Stanley L. Hem. (2004) Distribution of adsorbed antigen in mono-valent and combination vaccines. Vaccine 22:15-16, pages 1973-1984.
Crossref
Crossref
Seema Iyer, R.S.Robin Robinett, Harm HogenEsch & Stanley L. Hem. (2004) Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. Vaccine 22:11-12, pages 1475-1479.
Crossref
Crossref
Scott Jendrek, Stephen F. Little, Stanley Hem, Gautam Mitra & Steven Giardina. (2003) Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants. Vaccine 21:21-22, pages 3011-3018.
Crossref
Crossref